Novo Nordisk has announced it will invest 432m euros in its facility in Ireland. The tabletting facility, in Monksland, Athlone, will provide significant additional manufacturing capacity for current ...

Global events agency emc3 Collective has launched emc3 Life, a new healthcare-focused event agency created to meet growing demand for more human, innovative and sustainable healthcare and ...

Medivir has appointed Patrik Norgren as Chief Financial Officer (CFO). The Swedish pharmaceutical company is focused on ...

UK biotech N4 Pharma, a company developing a gene delivery system to enable advanced therapies for cancer and other diseases, ...

The US Food and Drug Administration (FDA) has issued draft guidance for sponsors seeking approval for targeted individualised ...

The Medscape Division of Public Health announced the launch of the "Where Public Health Meets Practice" Learning Center, a dedicated educational destination ...

Rare disease launches are complex by nature. Yet one of the most consistent risks we see is rarely treated as a launch issue at all: stigma.

Stop pushing content at a burnt-out audience and start creating "Digital Magnetism." Join Impetus Digital to unlock the 2026 ...

The study finds that healthcare settings are a leading source of stigma for people living with rare conditions ...

In a deal worth $950m, GSK has agreed to acquire 35Pharma, a private, clinical-stage biopharmaceutical company based in Canada that specialises in the development of novel protein-based therapeutics.

Precision intelligence offers a path forward – pharma-specific, human-led and already in use by teams managing complex, ...

Many of the people most engaged with our poster were already advocates, which may explain why the focus shifted quickly to ...